Moxifloxacin HCL 400 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3ZP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,491
Award facts
- Contract value 100% obligated
- $1,490.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 30, 2026, for Moxifloxacin HCL 400 mg tablets (30-count packages) with a ceiling value of $1,490.60 and an ultimate completion date of February 2, 2026. This firm fixed-price contract was competitively awarded without any set-aside designation, demonstrating the contractor's ability to meet federal procurement requirements through open competition. The award is structured as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the primary IDC with the Defense Logistics Agency. Through this vehicle, the contractor supplies a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs worldwide. The DLA Troop Support Medical's pharmaceutical prime vendor contracts represent critical infrastructure for federal medical procurement, enabling efficient delivery of essential medications and medical commodities to defense and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FG3ZP?
SPE2DR26FG3ZP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FG3ZP worth?
The government has obligated $1,491 on SPE2DR26FG3ZP.
Is contract SPE2DR26FG3ZP an order under another contract?
Yes. SPE2DR26FG3ZP is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3ZP competed?
The extent of competition for SPE2DR26FG3ZP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award